MEREDITH BRAZELL: Open Payments
NPI 1710396098 · SAINT MARYS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 17 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $229 · 2025 $520
Food & beverage: $520
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $158 |
| Medtronic, Inc. | 1 | $99 |
| Avadel CNS Pharmaceuticals, LLC | 4 | $86 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $69 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Abbott Laboratories | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $21 |
| Verona Pharma, Inc. | 1 | $20 |
Products named: MICRA, LUMRYZ, XIFAXAN, CAPLYTA, AMPLATZER AMULET, CAMZYOS, INSPIRE, MOUNJARO.
Industry payments across GA — which companies pay providers there.
